ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Kevin Gatter

NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK

Biography

Kevin Gatter is currently working as a Professor in the Department of Pathology,NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.The author's research interests include Clinical Pathology, Histopathology, Hemato Pathology, Surgical Pathology, Diagnosis. The author is serving as an editorial member and reviewer of several international reputed journals. The author has successfully completed his administrative responsibilities. The author has authorized many research articles/books related to Clinical Pathology, Experimental Pathology
Publications

Neoplastic Non-Angiogenic Growth by Means of Vascular Co-Option

The creation of the term angiogenesis goes back to 1787 [1] and the role of vessels in cancer has being studied since. In 1971 Folkman [2] introduced the hypothesis, until now widely accepted, that tumour growth is angiogenesis dependent [3]. However, the discovery that cancer can also grow without angiogenesis, by co-opting pre-existing vessels bo... Read More»

Francesco Pezzella and Kevin Gatter

Commentary: J Clin Exp Pathol 2015, 5: 232

DOI: 10.4172/2161-0681.1000232

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top